Bioscience Industry Leaders Will Gather in One Place on Oct. 16-17: Biotech 2006.Executives from the Tri-State Region For other tri-state regions, see . The Tri-State Region is commonly used in the area surrounding New York City to unambiguously refer to the greater metropolitan area. Sometimes the phrase is shortened to "the Tri-State," or "the Tri-State Area" is used instead. Will Meet at the Loews The name Loews can refer to several articles in the Wikipedia:
bi·o·sci·ence n. See life science. Industry TRENTON, N.J. & MALVERN, Pa. -- Biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. 2006: Imagine. Collaborate. Innovate in·no·vate v. in·no·vat·ed, in·no·vat·ing, in·no·vates v.tr. To begin or introduce (something new) for or as if for the first time. v.intr. To begin or introduce something new. (www.biotech2006.org) is the place to be as top industry leaders from the most dynamic bioscience companies in the Mid-Atlantic region meet to discuss the pressing issues facing the industry today. Throughout the two-day event, hosted jointly by the Biotechnology Council of New Jersey and Pennsylvania Pennsylvania (pĕnsəlvā`nyə), one of the Middle Atlantic states of the United States. It is bordered by New Jersey, across the Delaware River (E), Delaware (SE), Maryland (S), West Virginia (SW), Ohio (W), and Lake Erie and New York Bio, more than 80 speakers, including 46 C-Level executives, will be on hand to discuss their experiences working to grow companies and bring new therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. , devices, and diagnostic tests to patients. "The wide variety of programs and networking opportunities available to participants of Biotech 2006 are a direct reflection of the increasing importance of the biotechnology and life sciences industry in New Jersey, Pennsylvania and Delaware Delaware, state, United States Delaware (dĕl`əwâr, –wər), one of the Middle Atlantic states of the United States, the country's second smallest state (after Rhode Island). ," said Dr. Geert Cauwenbergh, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Barrier Therapeutics, Inc. "Like the industry itself, this meeting continues to grow and mature." "This joint symposium symposium In ancient Greece, an aristocratic banquet at which men met to discuss philosophical and political issues and recite poetry. It began as a warrior feast. Rooms were designed specifically for the proceedings. consistently draws industry leaders from across the region to share perspectives on our industry's growth, to discuss our challenges and celebrate our success. Fostering the regional industry is critical to our continued success, and this is the place where those connections and collaborations are made," said David R. King, CEO, BioRexis Pharmaceutical Corporation. Some of the program highlights include workshops focusing on stage of growth, finance models, off-shoring, drug delivery, diagnostics (1) Software routines that test hardware components (memory, keyboard, disks, etc.). Diagnostics are often stored in ROM chips and activated on startup. (2) Error messages in a programmer's source code that refer to statements or syntax that the compiler or assembler , hot topics in science, and global issues, including entering the Asia Pacific market place. There also will be a business development forum, an innovation corridor, an exhibit hall, and a career fair. In addition, Dr. Harlan F. Weisman, chief science and technology officer, Medical Devices & Diagnostics at Johnson & Johnson will present the keynote speech keynote speech n. See keynote address. Noun 1. keynote speech - a speech setting forth the keynote keynote address keynote - the principal theme in a speech or literary work on October 16 and G. Kelly Martin, president and CEO of Elan (Emulated LAN) A virtual LAN in the ATM world. See LANE and virtual LAN. Elan - ["Top-down Programming with Elan", C.H.A. Koster, Ellis Horwood 1987]. Corp., will give the keynote address keynote address n. An opening address, as at a political convention, that outlines the issues to be considered. Also called keynote speech. Noun 1. on October 17. To view the full list of speakers at Biotech 2006, all the topics to be addressed, and to register, please visit www.biotech2006.org. Media registration is available on the conference registration site. Participants include: CEOs: Geert Cauwenbergh, Ph.D., CEO, Barrier Therapeutics, Inc. David Cohen, MD, CEO, Founder, and Board Member, NaniRx Peter DeComo, Chairman and CEO, Renal Solutions, Inc. James Foley, Ph.D., CEO, SMART Biosciences John Gill, President, CEO, & Director TetraLogic Pharmaceuticals Martyn Greenacre, Chairman, Beijing Med-Pharm Ulrich Grau, Ph.D., President & CEO, Lux Biosciences Norman Hardman, Ph.D., President and CEO, Oxalis Partners LLC Robert Hariri, MD, Ph.D., CEO, Celgene Cellular Therapeutics Jason Jin, Ph.D., President & CEO, MaxyBio Corporation Joseph Kaufmann, President & CEO, Kensey Nash Corporation David King, CEO, BioRexis Pharmaceutical Corporation Antony Koblish, President & CEO, Orthovita, Inc. Ray Krauss, Founder & CEO, GlucoLight Corporation Ramesh Kumar, Ph.D., President & CEO, Onconova Therapeutics Maria-Luisa Maccecchini, Ph.D., CEO, Robin Hood Ventures John Maki, CEO, Vicus Therapeutics G. Kelly Martin, President & CEO, Elan Corporation, plc Kenneth I. Moch, Chairman, Alteon Inc. Sean McDonald, President & CEO, Precision Therapeutics, Inc. Steven Nichtberger, MD, President & CEO, Tengion, Inc. Jonathan Northrup, CEO, Horizon Biotechnologies, LLC Stuart Peltz, Ph.D., President & CEO, PTC Therapeutics Elizabeth Posillico, Ph.D., President & CEO, Elusys Therapeutics, Inc. Andrew Reaume, Ph.D., MBA, President & CEO, Melior Discovery, Inc. Spiro Rombotis, President & CEO, Cyclacel Pharmaceuticals Gail Schulze, President & CEO, YM Biosciences, Inc. C. Mark Tang, Ph.D., MBA, CEO, World Technology Ventures LLC Thomas Tillett, CEO, RheoGene Robert Towarnicki, President & CEO, Nucleonics, Inc. Peter Wang, CEO, China Biopharma, Inc. Dennis Willson, President & CEO, Cytokine PharmaSciences, Inc. CFOs: Robert Apple, Senior Vice President & CFO, Antares Pharma, Inc. Chip Baird, CFO, PTC Therapeutics Robert Dickey, IV, Vice President Finance & CFO, Locus Pharmaceuticals, Inc. Art Finnel, CFO, WellGen, Inc. Keith Goldan, CFO, PuriCore Thomas Hess, CPA, Vice President of Finance and CFO, Adolor Corporation Brian Lenz, CFO, VioQuest Pharmaceuticals, Inc. William Lewis, CFO and Vice President Administration, Aegrion Pharmaceuticals, Inc. Marc Rose, CPA, Vice President, Finance & CFO, Protalex, Inc. Christian Schade, Senior Vice President Finance and Administration & CFO, Medarex, Inc. COOs: Robert J. Hugin, President & COO, Celgene Corporation CSOs: Paul Hallenbeck, Ph.D., President, Director & CSO, Neotropix, Inc. Kishore Murthy, Ph.D., CSO and Operations Officer, GangaGen, Inc. Mark Smith, CSO, Neurotez, Inc. About Biotech 2006 Biotech 2006: Imagine. Collaborate. Innovate is designed to advance the growth and development of the bioscience industry in our region. In its sixth year, this event is a joint symposium of the Biotechnology Council of New Jersey and Pennsylvania Bio. For more information, please visit www.biotech2006.org. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion